Thymidine phosphorylase expression in invasive carcinoma: Correlations with clinicopathologic variables and in vitro chemosensitivity to 5-fluorouracil

Anticancer Research

Volumn 19, Issue 6 C, 1999, Pages 5543-5546

  Yang, Qifeng ^a   Shan, Liang ^a   Yoshimura, Goro ^a   Taniguchi, Emiko ^a   Suzuma, Takaomi ^a   Nakamura, Yasushi ^a   Nakamura, Misa ^a   Utsunomiya, Hirotoshi ^a   Tang, Weihua ^a   Sakurai, Takeo ^a   Kakudo, Kennichi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

5 fluorouracil; Breast cancer; Histoculture drug response assay; Thymidine phosphorylase

Indexed keywords

FLUOROURACIL; PROTEIN BCL 2; THYMIDINE PHOSPHORYLASE;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GRADING; CHEMOSENSITIVITY; CLINICAL FEATURE; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTIMETABOLITES, ANTINEOPLASTIC; BREAST NEOPLASMS; CARCINOMA; FEMALE; FLUOROURACIL; HUMANS; MIDDLE AGED; NEOPLASM INVASIVENESS; THYMIDINE PHOSPHORYLASE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0033390825     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Blood, CH and Zetter BR: Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1032: 89-118, 1990.
2. Fajardo LF, Kwan HH, Kowalski J, Prionas SD and Allison AC: Dual role of tumor necrosis factor-alpha in angiogenesis. Am J Pathol 140: 539-544, 1992.
3. Folkman J: What is the role of thymidine phosphorylase in tumor angiogenesis. J Natl Cancer Inst 88: 1091-1092, 1996.
4. Fox SB, Westwood M, Moghaddam A, Comley M, Turley H, Whitehouse RM, Bicknell, R, Gatter KC and Harris AL. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 73: 275-280, 1996.
5. O'Brien T, Cranston D, Fuggle S, Bicknell R and Harris AL: Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res 55: 510-513, 1995.
6. Patterson AV, Zhang H, Moghaddam A, Bicknell R, Talbot, DC, Soratford IJ and Harris AL: Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer 72: 669-675, 1995.
7. Reynolds K, Farzaneh F, Collins WP, Cambell S, Bourne TH, Lawton F, Moghaddam A, Harris AL and Bicknell R: Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 86: 1234-1238, 1994.
8. Iltzsch MH, eL Kouni MH and Cha S: Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 24: 6799-6807, 1985.
9. Schwartz EL, Hoffmam M, O'Conner CJ and Wadler S: Stimulation of 5-fluorouracil metabolic activation by interferon-a in human colon carcinoma cells. Biochim Biophys Res Comm 182: 1232-1239, 1992.
10. Bloom HJR and Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-377, 1957.
11. Furukawa T, Kubota T and Hoffman RM: Clinical application of the histocultrue drug response assay. Clin Cancer Res 1: 305-311, 1995.
12. Yonenaga F, Takashi T, Ohi Y, Sagara Y, Akiba S, Yoshinaka H, Aikou T, Miyadera K, Akiyama S and Yoshida H: The expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor is correlated to angiogenesis in breast cancer. Pathol Int 48: 850-856, 1998.
13. Eda H, Fujimoto K, Watanabe S, Ura M, Hino A, Tanaka Y, Wada K and Ishistuka H: Cytokines induce thymidine phosphorylase expression in tumor-cells and make them more susceptible to 5'-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 32: 333-338, 1993.
14. Griffiths L, Dachs GU, Bicknell R, Harris AL and Stratford IJ: The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res 57: 570-572, 1997.
15. Ishikawa F, Miyazono K, Hellman U, Drexere H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W and Heldin CH: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557-562, 1989.
16. Leek RD, Landers R, Fox SB, Ng F, Harris AL and Lewis CE: Association of tumor necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br J Cancer 77: 2246-2251, 1998.
17. Wu J: Apoptosis and angiogenesis: two promising tumor markers in breast cancer. Anticancer Res 16: 2233-2239, 1996.
18. Zhang GJ, Kimijima I, Abe R, Watanabe T, Kanno M, Hara K and Tsuchiya A: Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers. Anticancer Res 18: 1989-1998, 1998.
19. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishitsuka H and Tominaga T: Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 64: 79-82, 1995.
20. Schwartz EL, Baptiste N, Wadler S and Makower D: Thymidine phosphorylas̀e mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. J Biol Chem 270: 19073-19077, 1995.
21. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.